Prescient Therapeutics Ltd News

Prescient Therapeutics Ltd: Prescient CEO to step down in early 2025

Sep 12 06:31

Prescient Therapeutics Ltd: PTX Presentation

Sep 5 07:25

Prescient Therapeutics Ltd: Appendix 4G and Corporate Governance Statement

Aug 26 07:55

Prescient Therapeutics Ltd: Appendix 4E and 2024 Annual Report

Aug 26 07:54

Prescient Therapeutics Ltd: June 2024 Quarterly Update and Appendix 4C

Jul 31 07:44

Prescient Therapeutics Ltd: Initial Director's Interest Notice

Jul 5 10:22

Prescient Therapeutics Ltd: PTX appoints Dr Gavin Shepherd as Non-Executive Director

Jul 4 11:53

Prescient Therapeutics Ltd: Notification of cessation of securities - PTX

Jun 4 12:14

Prescient Therapeutics Ltd: Change of Director's Interest Notice

Jun 4 12:09

Prescient Therapeutics Ltd: PTX invited to present at international lymphoma forum

May 20 07:37

Prescient Therapeutics Ltd: March 2024 Quarterly Update and Appendix 4C

Apr 30 07:57

Prescient Therapeutics Ltd: PTX100 Ph1b results to be presented at specialist congress

Apr 8 10:39

Prescient Therapeutics Ltd: Notification of cessation of securities - PTX

Apr 5 09:55

Prescient Therapeutics Ltd: Appendix 4D and Half Year Financial Report

Feb 23 07:14

Prescient Therapeutics Ltd: December 2023 Quarterly Update and Appendix 4C

Jan 31 08:52

Prescient Therapeutics Ltd: PTX-100 Spotlight Presentation

Dec 18, 2023 07:53

Prescient Therapeutics Ltd: PTX-100 Ph1b results show excellent safety & efficacy in TCL

Dec 11, 2023 05:32

Prescient Therapeutics Ltd: Prescient Receives $2.4 Million R&D Tax Rebate

Nov 28, 2023 06:20

Prescient Therapeutics Ltd: Results of Annual General Meeting

Nov 16, 2023 14:53

Prescient Therapeutics Ltd: Chair and CEO AGM Presentation

Nov 16, 2023 09:00